Honey Goel

About

The current field of my research work is primarily focused on targeted drug delivery of dissolution rate limited/poorly soluble drugs to colon or Site specific release of conventional anticancer drugs to gastrointestinal cancers, Colon cancer biology, cancer chemoprevention using adjuvant therapy, design and development using biodegradable natural polymers, Orally modified drug delivery systems (orodispersible tablets, solid lipid nano particles) Particle coating, spray drying and lyophilization techniques, In-silico prediction of ADME properties using SOMFA, Statistical Optimization of formulation variables using 32 factorial designs

Employment

• Baba Farid University of Health Sciences Assistant Professor
  2013 - Present
• Panjab University Senior Research Fellow (UGC-RFSMS fellow)
  2008 - 2013

Education

• Panjab University Ph.D.
  2008 - 2015
• Punjabi University M. Pharm.
  2006 - 2008
• Punjabi University B. Pharm.
  2002 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (26)

• Pathophysiological and Etiological Corroborations for the Mechanistic Design of Intranasal Therapies in Glioblastoma Multiforme
  Current Pharmaceutical Design 2026 DOI: 10.2174/0113816128373247250529114324
  +Save
• Fathoming biopharmaceutical tenets and characterization techniques for the plausible ophthalmic drug delivery performance
  2023 DOI: 10.1016/B978-0-443-15264-1.00006-3
  +Save
• Biocompatible Nanovesicular Drug Delivery Systems with Targeting Potential for Autoimmune Diseases
  Current Pharmaceutical Design 2020 DOI: 10.2174/1381612826666200523174108
  +Save
• Engineered Site-specific Vesicular Systems for Colonic Delivery: Trends and Implications
  Current Pharmaceutical Design 2020 DOI: 10.2174/1381612826666200813132301
  +Save
• Facile validated HPLC method using photodiode array detector for the combined analysis of etodolac and 5-FU in bulk and tablet dosage form
  Egyptian Journal of Chemistry 2020
  +Save
• Toxicological and biochemical assessment of specific COX-2 inhibitor as adjuvant in fluoropyrimidine therapy in chemically induced colon cancer
  Annals of Oncology 2016
  +Save
• A Novel synergistic approach to exploit the bactericidal efficacy of commercial disinfectants on the biofilms of Salmonella enterica serovar Typhimurium
  Journal of bioscience and bioengineering 2014 DOI: 10.1016/j.jbiosc.2013.12.025
  +Save
• Self-organizing molecular field analysis of NSAIDs: Assessment of pharmacokinetic and physicochemical properties using 3D-QSPkR approach
  European Journal of Medicinal Chemistry 2012 DOI: 10.1016/j.ejmech.2012.03.037
  +Save
• Critical Aspects in Rationale Design of Fluorouracil based Adjuvant Therapies for the Management of Colon cancer
  Critical Reviews in Therapeutic Drug Carrier Systems 2012
  +Save
• In Silico Predicative Studies for Cytotoxic Potential of NSAIDs Using Self-Organizing Molecular Field Analysis
  International journal of toxicology 2012 DOI: 10.1177/1091581812444140
  +Save